Instrument Inactif

Communiqués Diplomat Pharmacy, Inc.

Actions

DPLO

Pharmacies

Communiqués

10/02/20	DIPLOMAT PHARMACY, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
31/12/19	DIPLOMAT PHARMACY, INC. : Other Events (form 8-K)	AQ
11/12/19	DIPLOMAT ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of DPLO and Encourages Investors to Contact the Firm	PR
09/12/19	DIPLOMAT PHARMACY, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
12/11/19	Diplomat Pharmacy : Announces 3rd Quarter Financial Results; Updates 2019 Guidance	PR
30/10/19	Diplomat Pharmacy : to Release Third-Quarter 2019 Operating Results Nov. 12	PR
16/10/19	Diplomat Pharmacy : Announces Sale of Certain Assets of Envoy Health Management, LLC to Diligent Health Solutions, LLC	PR
02/10/19	Diplomat Pharmacy : Announces Promotion of David Skomo to Chief Operating Officer of CastiaRx	PR
09/08/19	Diplomat Pharmacy : Announces 2nd Quarter Financial Results; Updates 2019 Guidance	PR
09/08/19	Diplomat Pharmacy : Announces Review of Strategic Alternatives	PR
08/08/19	Diplomat Pharmacy : signs exclusive practice-based infusion agreement with Allergy Partners	PR
18/07/19	Diplomat Pharmacy : to Release Second-Quarter 2019 Operating Results August 9	PR
15/07/19	(DPLO) Alert: Johnson Fistel, LLP Announces Investigation of Diplomat Pharmacy, Inc.; Long Term Investors Encouraged to Contact Firm	PR
09/07/19	Diplomat Pharmacy : Launches Empower Ecosystem Patient Support Digital Library	PR
07/05/19	Diplomat Pharmacy : Announces 1st Quarter Financial Results	PR
06/05/19	Diplomat Pharmacy : Appoints Dave Loschinskey as Chief Operating Officer	PR
25/04/19	Diplomat Pharmacy : Using SMRxT Technology to Enhance Patient Care	PR
25/04/19	DIPLOMAT PHARMACY 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Diplomat Pharmacy, Inc. - DPLO	BU
17/04/19	Diplomat Pharmacy : to Release First-Quarter 2019 Operating Results May 7, Participate in Bank of America Merrill Lynch Healthcare Conference May 14	PR
15/04/19	DPLO CLASS ACTION REMINDER: Hagens Berman Reminds Diplomat Pharmacy (DPLO) of Securities Class Action, Encourages Investors to Contact the Firm	PR
10/04/19	Diplomat Pharmacy : Expands AdhereTech Relationship as Program Shows Increased Adherence and Persistence	PR
09/04/19	Diplomat Pharmacy : Grants Chief Financial Officer Dan Davison Inducement Awards Pursuant to NYSE Rule 303A.08	PR
30/03/19	DIPLOMAT PHARMACY ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Diplomat Pharmacy, Inc. - DPLO	BU
17/03/19	Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors of Important Deadline in Securities Class Action Filed by the Firm - DPLO	PR
15/03/19	Johnson Fistel, LLP : Files Class Action Suit against Diplomat Pharmacy, Inc.	PR